Endometrial Ablation Market Size, Share & Trends Analysis Report By Type (Procedures, Devices), By End Use (Hospital, ASC), By Region (Asia Pacific, Europe, North America), And Segment Forecasts, 2021 - 2028
Endometrial Ablation Market Growth & Trends
The global endometrial ablation market size is expected to reach USD 5.4 billion by 2028, registering a CAGR of 5.2% over the forecast period, according to a new report by Grand View Research, Inc. Endometrial ablation is a highly efficient procedure that helps in removing or destroying the uterine endometrial lining in women who experience heavy menstrual bleeding using specific devices. The growing prevalence of gynecological disorders and growing public awareness about endometrial ablation are key contributing factors expected to propel the product demand. According to the International Federation of Gynecology and Obstetrics (FIGO), globally, the prevalence of Abnormal Uterine Bleeding (AUB) among reproductive-aged women is estimated to be between 3 to 30%
For women suffering from painful, heavy periods, endometrial ablation for endometriosis offers an alternative to chronic medication and hysterectomy treatments. Improved features and a higher demand for these procedures and devices due to the advantages over surgical methods, such as minimally invasive nature, low-risk profile, and easy operation, will support market growth. Many global, as well as local key players, are opting for different strategies. For instance, In March 2020, Mara Water Vapor Ablation System from AEGEA Medical has been approved by the U.S. FDA. Mara is the endometrial ablation procedure that uses natural water vapor to safely cure heavy menstrual bleeding without the need for general anesthesia.
Endometrial ablation procedures have proven effective in about 10% of people to no longer have menstrual periods. Bleeding is effectively decreased in another 70% of cases. However, there are certain side effects associated with the procedure, which include infection, tearing of the uterine wall or bowel, which may hamper the market growth. As a result of the COVID-19 pandemic, the healthcare system had to deal with a lot of difficulties, all outpatient procedures were limited or stopped to lower the impact of virus outbreaks. This also had a negative impact on the overall market growth.
Endometrial Ablation Market Report Highlights
- The radiofrequency ablation device segment dominated the market with a revenue share of 26.3% in 2020
- The segment is expected to continue its dominance during the forecast period
- The thermal balloon segment is expected to grow at a significant rate during the forecast period
- The hospital end-use segment held the largest revenue share of more than 55% in 2020
- The high growth is credited to the availability of technologically improved medical devices in hospitals
- The Ambulatory Surgery Center (ASC) end-use segment is expected to exhibit the fastest CAGR during the forecast period
- ASCs have shorter stay duration, little or no danger of Hospital-Acquired Infections (HAIs), and are more convenient than other healthcare facilities
Please note The report will be delivered in 2-3 business days upon order notification.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. End - use
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. End - use outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Endometrial Ablation Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Rising number of uterine problems
- 3.4.1.2. Increasing preference to minimally invasive procedures
- 3.4.2. Market restraint analysis
- 3.4.2.1. High treatment costs
- 3.4.2.2. Presence of alternative treatment options
- 3.5. Endometrial Ablation Market Analysis Tools
- 3.5.1. Industry Analysis – Porter’s
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies
- Chapter 4. Endometrial Ablation Market: Type Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Devices
- 4.1.2. Procedures
- 4.2. Type Market Share, 2020 & 2028
- 4.3. Segment Dashboard
- 4.4. Global Endometrial Ablation Market by Type Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
- 4.5.1. Devices
- 4.5.1.1. Devices market estimates and forecast 2016 to 2028 (USD Million)
- 4.5.1.2. Cryoablation
- 4.5.1.2.1. Cryoablation market estimates and forecast 2016 to 2028 (USD Million
- 4.5.1.3. Radiofrequency Ablation
- 4.5.1.3.1. Radiofrequency ablation market estimates and forecast 2016 to 2028 (USD Million)
- 4.5.1.4. Hydrothermal Ablation
- 4.5.1.4.1. Hydrothermal ablation market estimates and forecast 2016 to 2028 (USD Million)
- 4.5.1.5. Thermal Balloon
- 4.5.1.5.1. Thermal Balloon market estimates and forecast 2016 to 2028 (USD Million)
- 4.5.1.6. Microwave Energy
- 4.5.1.6.1. Microwave energy market estimates and forecast 2016 to 2028 (USD Million)
- 4.5.2. Procedures
- 4.5.2.1. Procedures market estimates and forecast 2016 to 2028 (USD Million)
- Chapter 5. Endometrial Ablation Market: End - Use Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Hospital
- 5.1.2. Clinic
- 5.1.3. Ambulatory Surgery Center
- 5.2. End - use Market Share, 2020 & 2028
- 5.3. Segment Dashboard
- 5.4. Global Endometrial Ablation Market by End - Use Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
- 5.5.1. Hospital
- 5.5.1.1. Hospital market estimates and forecast 2016 to 2028 (USD Million)
- 5.5.2. Clinic
- 5.5.2.1. Clinic market estimates and forecast 2016 to 2028 (USD Million)
- 5.5.3. Ambulatory Surgery Center
- 5.5.3.1. Ambulatory surgery center market estimates and forecast 2016 to 2028 (USD Million)
- Chapter 6. Endometrial Ablation Market: Regional Estimates & Trend Analysis
- 6.1. Regional market share analysis, 2020 & 2028
- 6.2. Regional Market Dashboard
- 6.3. Global Regional Market Snapshot
- 6.4. Regional Market Share and Leading Players, 2020
- 6.4.1. North America
- 6.4.2. Europe
- 6.4.3. Asia Pacific
- 6.4.4. Latin America
- 6.4.5. Middle East and Africa
- 6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 6.5.1. North America
- 6.5.2. Europe
- 6.5.3. Asia Pacific
- 6.5.4. Latin America
- 6.5.5. Middle East and Africa
- 6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2016 to 2028:
- 6.7. North America
- 6.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.7.2. U.S.
- 6.7.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.7.3. Canada
- 6.7.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.8. Europe
- 6.8.1. U.K.
- 6.8.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.8.2. Germany
- 6.8.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.8.3. France
- 6.8.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.8.4. Italy
- 6.8.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.8.5. Spain
- 6.8.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.8.6. Norway
- 6.8.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.8.7. Sweden
- 6.8.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.8.8. Russia
- 6.8.8.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.9. Asia Pacific
- 6.9.1. Japan
- 6.9.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.9.2. India
- 6.9.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.9.3. China
- 6.9.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.9.4. Australia
- 6.9.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.9.5. South Korea
- 6.9.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.10. Latin America
- 6.10.1. Brazil
- 6.10.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.10.2. Mexico
- 6.10.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.10.3. Argentina
- 6.10.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.10.4. Colombia
- 6.10.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.11. MEA
- 6.11.1. Saudi Arabia
- 6.11.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.11.2. Turkey
- 6.11.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.11.3. UAE
- 6.11.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.11.4. Qatar
- 6.11.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.11.5. South Africa
- 6.11.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.2.1. Innovators
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company market share analysis, 2020
- 7.3.4. Medtronic
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. CooperSurgical Inc.
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Boston Scientific Corporation
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Ethicon, Inc. (Johnson & Johnson)
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Olympus Corporation
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. Richard Wolf GmbH
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. AngioDynamics
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Product benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. Hologic, Inc.
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Product benchmarking
- 7.3.11.4. Strategic initiatives
- 7.3.12. Minerva Surgical, Inc.
- 7.3.12.1. Company overview
- 7.3.12.2. Financial performance
- 7.3.12.3. Product benchmarking
- 7.3.12.4. Strategic initiatives